Clinical trial · Interventional
Improving Sensitivity of Urine Cytology for Bladder Cancer
Non-Invasive Vibrational Device to Improve Sensitivity of Urine Cytology for Bladder Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Can a commercially available vibrating chair increase the number of urothelial cells in a urine sample of healthy participants non-invasively? The investigators plan is participants will alternate 15 minutes of drinking eight fluid ounces of water and 15 minutes of sitting in the vibrating chair for one hour. The control group will alternate 15 minutes of drinking eight fluid ounces of water and 15 minutes of sitting in a non-vibrating chair for one hour. Then, urine samples will be collected and examined for urothelial cell concentration for both groups.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| La-Z-Boy Massage Chair Vibration Effect on Bladder Cancer Cell Concentration | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Vibration
- description
- Whole body vibration applied to a group of 20 bladder cancer patients.
- interventionNames
- Device: La-Z-Boy Massage Chair Vibration Effect on Bladder Cancer Cell Concentration
Primary outcomes (1)
- measure
- Number of Cancer Cells
- timeFrame
- up to 24 weeks
- description
- Number of Cancer Cells in a 50 ml Urine
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Only adult male subjects who will not have surgery within a period of 2 weeks. * Over the age of 18 * Have had a confirmed diagnosis of stage 0-4 transitional cell carcinoma within the last 30 days Exclusion Criteria: * Cognitive impairment resulting in the inability to give informed consent * Lack of spoken and written English resulting in the inability to give informed consent * Presence of infectious disease * Insulin dependent diabetes mellitus * Endogenous osteosynthetical material implants * Knee or hip prosthesis * Pacemaker * Epilepsy * Musculo-skeletal disorders * Weight in excess of 250 pounds * Poor circulation
References
Publications (0)
Data not yet available